The FDA issued an alert for one of Becton Dickinson's coronavirus tests due to an increased risk of false-positive results.
Shares of Becton Dickinson & Co. were down 0.7% in premarket trading on Tuesday, the day after the Food and Drug Administration issued an alert about an increased risk of false-positive results for o
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the availability of BD PurPrep™ patient preoperative skin preparation with sterile soluti
Association for Project Management (APM), results of a study of the contribution of project management in the UK healthcare sector
Healthcare technology specialist Becton, Dickinson (NYSE: BDX) announced Monday that it has been granted Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA) for an antigen
The U.S. Food and Drug Administration alerted clinical laboratories and healthcare providers on Monday about false positive results from one of Becton Dickinson and Co's COVID-19 molecular diagnostic
Becton Dickinson gained U.S. authorization for its third coronavirus test on Monday, sending BDX stock higher at the close. Gilead Sciences and Mylan also gained remdesivir nods.
• Miami is closing restaurants for both indoor and outdoor dining again, along with “ballrooms, banquet facilities, party venues, gyms and fitness centers, and short-term rentals,” Mayor Carlos
Stock of San Diego-based medical device company hits one-year high Continue reading...

Coronavirus latest: Monday, July 6

07:39pm, Monday, 06'th Jul 2020
The United States topped over 130,000 new cases of coronavirus over the 4th of July holiday weekend, with Florida and Texas breaking new daily case records. Yahoo Finance’s Anjalee Khemlani breaks d
Salesforce.com has a significant presence in the healthcare segment and there are indications of continued strong momentum.
Becton Dickinson said it was cleared by the FDA to market a 15-minute coronavirus diagnostic test and will begin shipping the test this week.
Shares of Becton Dickinson & Co. gained 3.6% in premarket trading on Monday after the diagnostics company announced the launch of a point-of-care COVID-19 antigen test that can detect the coronavirus
Becton Dickinson shares rose $5.40, or 2.3%, to $250.61 in early trading. The authorization was based on a robust sample size of 226 specimens from sites across the United States, Evercore ISI analys
Regulatory News: Median Technologies (Paris:AMLDT), The Imaging Phenomics Company® (ALMDT) announced today that it has been awarded the Euronext Europ
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE